HMGB1 and neoplasm: Zhou et al. [49] also reported that recombinant HMGB1 can rapidly activate NF-κB in DU145 tumor cells, then induce the production of sCLU (cytoplasmic lectin) and increase the tolerance of residual tumor cells to DTX.